However, Aβ and tau levels are not sufficient for a clinical diagnosis of AD, instead positron emission tomography (PET) scans to detect amyloid plaques or tau tangles can be used to confirm a clinical diagnosis. Here, MAPT is linked to Alzheimer disease.